Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.
Luo Y, Lai XY, Tan YM, Shi JM, Zhao YM, Han XY, Zheng GF, Zhu XL, Sun J, Zheng YL, Wu GQ, He JS, Chen SY, Jin AY, Xie WZ, Ye XJ, Cai Z, Lin MF, Huang H.
Luo Y, et al. Among authors: cai z.
Leukemia. 2009 Jun;23(6):1171-4. doi: 10.1038/leu.2008.401. Epub 2009 Feb 5.
Leukemia. 2009.
PMID: 19194468
No abstract available.